In today’s episode, I sit down with Jim Tananbaum, founder and CEO of Foresite Capital, to talk about how a background in medicine and math can shape the future of healthcare. He explains how early research exposure at Harvard and MIT led to a strategy that connects long-term vision with measurable impact. We get into why sequencing all 20,000 genes is more useful than collecting endless data, and how AI is helping tailor healthcare without overcomplicating it. Jim also shares how purpose, persistence, and the right partnerships have guided his decisions across decades of transformation in biotech, venture capital, and personal health.
